Cargando…
Clinical efficacy and safety of anticholinergic therapies in pediatric patients
The burden of uncontrolled asthma in children and adolescents is high. Treatment options for pediatric patients (aged under 18 years) with asthma are largely influenced by the Global Initiative for Asthma recommendations. Algorithms for adolescents (12–18 years) and adults are identical, but recomme...
Autor principal: | Goldstein, Stanley |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422407/ https://www.ncbi.nlm.nih.gov/pubmed/30936706 http://dx.doi.org/10.2147/TCRM.S161362 |
Ejemplares similares
-
Safety and tolerability of inhalational anticholinergics in COPD
por: Sharafkhaneh, Amir, et al.
Publicado: (2013) -
The Role of Dexmedetomidine in Pediatric Patients Presenting with an Anticholinergic Toxidrome
por: Zekhtser, Mitchell, et al.
Publicado: (2021) -
The development of anticholinergics in the management of COPD
por: Scullion, Jane E
Publicado: (2007) -
The past, present and future of anticholinergic drugs
por: Healy, David
Publicado: (2023) -
The Efficacy and Safety of Propiverine Hydrochloride in Patients with Overactive Bladder Symptoms Who Poorly Responded to Previous Anticholinergic Agents
por: Masumori, Naoya, et al.
Publicado: (2011)